Nanjing Well Pharmaceutical Co Ltd (603351) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Nanjing Well Pharmaceutical Co Ltd (603351) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.51 Million ≈ $10.17 Million USD) by net assets (CN¥1.77 Billion ≈ $258.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Nanjing Well Pharmaceutical Co Ltd (603351) total market value for the company's overall valuation and market capitalisation.

Nanjing Well Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nanjing Well Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanjing Well Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Well Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Nanjing Well Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Bouvet OL:BOUV	0.819x
Grupo Empresarial San Jose SA MC:GSJ	0.139x
Altice USA Inc NYSE:ATUS	-0.066x
Titan Machinery Inc NASDAQ:TITN	0.308x
Changzhou Shenli Electrical Machine Incorporated Co SHG:603819	0.017x
Mill City Ventures III Ltd NASDAQ:MCVT	0.015x
Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret AS IS:BRISA	0.058x
Bewi Asa OL:BEWI	0.034x

Annual Cash Flow Conversion Efficiency for Nanjing Well Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025. View today's stock price for Nanjing Well Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.80 Billion ≈ $263.81 Million	CN¥238.24 Million ≈ $34.86 Million	0.132x	+1.78%
2024-12-31	CN¥1.71 Billion ≈ $249.96 Million	CN¥221.79 Million ≈ $32.46 Million	0.130x	+71.98%
2023-12-31	CN¥1.59 Billion ≈ $233.06 Million	CN¥120.24 Million ≈ $17.60 Million	0.075x	+2.69%
2022-12-31	CN¥1.48 Billion ≈ $216.92 Million	CN¥108.99 Million ≈ $15.95 Million	0.074x	+982.90%
2021-12-31	CN¥1.39 Billion ≈ $202.73 Million	CN¥-11.54 Million ≈ $-1.69 Million	-0.008x	-111.60%
2020-12-31	CN¥1.30 Billion ≈ $190.18 Million	CN¥93.30 Million ≈ $13.65 Million	0.072x	-31.29%
2019-12-31	CN¥1.24 Billion ≈ $181.63 Million	CN¥129.69 Million ≈ $18.98 Million	0.104x	+0.72%
2018-12-31	CN¥614.61 Million ≈ $89.94 Million	CN¥63.76 Million ≈ $9.33 Million	0.104x	-22.45%
2017-12-31	CN¥532.80 Million ≈ $77.96 Million	CN¥71.27 Million ≈ $10.43 Million	0.134x	-53.67%
2016-12-31	CN¥443.99 Million ≈ $64.97 Million	CN¥128.18 Million ≈ $18.76 Million	0.289x	+4.79%
2015-12-31	CN¥294.49 Million ≈ $43.09 Million	CN¥81.14 Million ≈ $11.87 Million	0.276x	-11.25%
2014-12-31	CN¥240.35 Million ≈ $35.17 Million	CN¥74.62 Million ≈ $10.92 Million	0.310x	--

About Nanjing Well Pharmaceutical Co Ltd

SHG:603351 China Drug Manufacturers - Specialty & Generic

Market Cap

$501.82 Million

CN¥3.43 Billion CNY

Market Cap Rank

#12334 Global

#3596 in China

Share Price

CN¥25.32

Change (1 day)

-1.17%

52-Week Range

CN¥22.85 - CN¥30.12

All Time High

CN¥40.56